Related Experiment Video
Updated: Apr 16, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Inflammatory and cell death pathways in brain and peripheral blood in Parkinson's disease
Beatrice Macchi1, Rosanna Di Paola, Francesca Marino-Merlo
1Department of System Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy. macchi@uniroma2.it.
Abstract:
Evidence has been accumulated showing that inflammatory and cell death pathways are altered both in brain and periphery during Parkinson disease (PD). Neuronal loss in PD is associated with chronic neuroinflammation characterized by microglia activation through the release of reactive oxygen radicals, cytokines, and Prostaglandin E2. The release of these inflammatory mediators in addition to deprivation in growth factors and increase of calcium and dopamine seem implicated in triggering apoptosis. The interaction of leucine-rich repeat kinase and Fas- Associated protein with Death Domain has been implicated in the switching-on of the extrinsic apoptotic pathway via caspase-8 activation, while deficiency in PTEN induced putative kinase 1 has been shown to cause Ca2+ accumulation in mitochondria, increased generation of reactive oxygen species and intrinsic cell death. Autophagy/mitophagy appears to be impaired in the brain during PD; this impairment could be related to defective degradation of mutant α-synuclein and consequent apoptotic cell death. Regarding the peripheral blood, reduced amounts of dopamine, reduced levels of immunoreactivity for tyrosine hydroxylase and dopamine active transporter, and alterations of dopamine receptor expression have been detected in mononuclear cells from PD patients. In addition, mononuclear cells from PD patients show mitochondrial, ubiquitin-proteasome system dysfunction and up-regulation of α-synuclein gene, associated to high expression of the Fas molecule, activation of caspase-3 and -9 and proneness to apoptosis. These and other observations reported in this mini-review suggest that a better understanding of molecular dysfunctions in inflammatory and cell death/autophagy pathways, both in the brain and peripheral blood, could provide useful targets for future investigation on drug-discovery and biomarker identification in PD.
Insights
Parkinson disease involves altered brain and blood cell inflammation and cell death pathways. Understanding these molecular changes may reveal new drug targets and biomarkers for Parkinson disease.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Parkinson disease (PD) is characterized by neuroinflammation and neuronal loss.
- Microglia activation releases inflammatory mediators, contributing to apoptosis.
- Altered cell death and autophagy pathways are implicated in PD pathogenesis.
Purpose of the Study:
- To review the molecular dysfunctions in inflammatory and cell death pathways in Parkinson disease.
- To explore potential therapeutic targets and biomarkers for PD.
Main Methods:
- Review of existing evidence on molecular pathways in PD.
- Analysis of inflammatory mediators, cell death signaling, and autophagy.
- Examination of peripheral blood mononuclear cell alterations in PD patients.
Main Results:
- Neuroinflammation, apoptosis, and impaired autophagy are key features in PD brain.
- Peripheral mononuclear cells in PD patients exhibit mitochondrial dysfunction, α-synuclein upregulation, and apoptosis proneness.
- Alterations in dopamine-related markers are observed in PD patient blood cells.
Conclusions:
- Dysregulation of inflammatory and cell death pathways is evident in both the brain and periphery in PD.
- Further understanding of these molecular pathways could lead to novel drug discovery and biomarker identification for Parkinson disease.
Related Concept Videos
Parkinson's Disease: Overview
Neural Regulation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Inflammation
The Blood-brain Barrier
